share_log

Teladoc Health | 8-K: Teladoc Health Reports Second Quarter 2024 Results

Teladoc Health | 8-K: Teladoc Health Reports Second Quarter 2024 Results

Teladoc Health | 8-K:Teladoc Health 公佈2024年第二季度業績
美股SEC公告 ·  07/31 16:08

Moomoo AI 已提取核心訊息

On July 31, 2024, Teladoc Health, Inc. reported its financial results for the second quarter of 2024. The company experienced a 2% decrease in revenue year-over-year, totaling $642.4 million. Notably, the quarter included a substantial net loss of $837.7 million, or $4.92 per share, largely due to a goodwill impairment charge of $790.0 million related to its BetterHelp segment. Despite the overall net loss, Teladoc Health's adjusted EBITDA rose by 24% to $89.5 million. The Integrated Care segment saw a revenue increase of 5% to $377.4 million, while the BetterHelp segment's revenue declined by 9% to $265.0 million. The company's new CEO, Chuck Divita, acknowledged the need to address performance challenges and streamline operations. Teladoc Health has withdrawn its full-year 2024 financial outlook for both its Consolidated operations and BetterHelp segment, previously provided on April 25, 2024. The earnings conference call took place on the same day as the report release.
On July 31, 2024, Teladoc Health, Inc. reported its financial results for the second quarter of 2024. The company experienced a 2% decrease in revenue year-over-year, totaling $642.4 million. Notably, the quarter included a substantial net loss of $837.7 million, or $4.92 per share, largely due to a goodwill impairment charge of $790.0 million related to its BetterHelp segment. Despite the overall net loss, Teladoc Health's adjusted EBITDA rose by 24% to $89.5 million. The Integrated Care segment saw a revenue increase of 5% to $377.4 million, while the BetterHelp segment's revenue declined by 9% to $265.0 million. The company's new CEO, Chuck Divita, acknowledged the need to address performance challenges and streamline operations. Teladoc Health has withdrawn its full-year 2024 financial outlook for both its Consolidated operations and BetterHelp segment, previously provided on April 25, 2024. The earnings conference call took place on the same day as the report release.
2024年7月31日,teladoc health公司公佈了2024年第二季度的財務報告。公司營業收入同比下降2%,總計64240萬美元。值得注意的是,該季度淨損失額爲83770萬美元,每股虧損4.92美元,主要是由於其BetterHelp業務相關的79000萬元商譽減值費用。儘管整體淨虧損,但teladoc health的調整後EBITDA增長了24%,達到8950萬美元。綜合護理業務板塊的營業收入增長了5%,達到37740萬美元,而BetterHelp業務板塊的營業收入下降了9%,僅有26500萬元。公司的新任CEO Chuck Divita 承認了需要解決的績效挑戰和優化業務等問題。teladoc health已經撤回了2024年全年財務展望,包括Consolidated operations和BetterHelp業務板塊,在此之前是在2024年4月25日公佈的。業績會議與報告發布在同一天舉行。
2024年7月31日,teladoc health公司公佈了2024年第二季度的財務報告。公司營業收入同比下降2%,總計64240萬美元。值得注意的是,該季度淨損失額爲83770萬美元,每股虧損4.92美元,主要是由於其BetterHelp業務相關的79000萬元商譽減值費用。儘管整體淨虧損,但teladoc health的調整後EBITDA增長了24%,達到8950萬美元。綜合護理業務板塊的營業收入增長了5%,達到37740萬美元,而BetterHelp業務板塊的營業收入下降了9%,僅有26500萬元。公司的新任CEO Chuck Divita 承認了需要解決的績效挑戰和優化業務等問題。teladoc health已經撤回了2024年全年財務展望,包括Consolidated operations和BetterHelp業務板塊,在此之前是在2024年4月25日公佈的。業績會議與報告發布在同一天舉行。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息